In the subset of GIST without any alterations of the KIT/PDGFRA/SDH/RAS pathway, targeted sequencing of so-called quadruple wild-type GIST has shown the presence of activating mutations or gene fusions involving FGFR1. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.